Key facts
- This page summarizes Dashyant Dhanak's Form 4 filing for INCYTE CORP (INCY).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jul 2023, 16:00.
Dashyant Dhanak - 14 Jul 2023 Form 4 Insider Report for INCYTE CORP (INCY)
- Reporting relationship
- EVP & Chief Scientific Officer
- Issuer ticker
- INCY
- Reported as of
- 14 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jul 2023, 16:00:18 UTC
- Prior SEC filing
- 06 Jul 2023
- Next SEC filing
- 05 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Elizabeth Feeney, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dashyant Dhanak filed Form 4 for INCYTE CORP (INCY) on 18 Jul 2023.
Change
- Previous filing in this sequence was filed on 06 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INCY
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +8,056
- Change %
- +16%
- Price
- $0.000000
- Shares after
- 58,968
- Date
- 14 Jul 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INCY
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +16,896
- Change %
- Price
- $0.000000
- Shares after
- 16,896
- Date
- 14 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,896
- Exercise price
- $61.76
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Footnote F2
Including the July 14, 2023 RSU Grant, this includes an aggregate of 53,279 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
Footnote F3
The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.